Cognizant Slides as Index Exit and Soft Near-Term Sentiment Weigh on Shares

Cognizant Technology Solutions (CTSH) is down 3.0% today. Here is some analysis on what might have caused this price movement.

Analysis: The most likely driver is continued selling pressure after CTSH was slated to leave the Nasdaq-100 effective June 22, a change that can trigger repositioning by index-linked investors. The move may also reflect lingering caution toward traditional IT services names, even though Cognizant’s latest quarter showed solid bookings growth, unchanged revenue guidance, and a recently expanded buyback plan.

Details:

A June 11 index rebalance notice listed Cognizant among the companies being removed before the June 22 market open, which can create technical pressure as passive funds and benchmark-focused traders adjust holdings.

Cognizant’s first-quarter release showed revenue of $5.4 billion, 21% first-quarter bookings growth, and unchanged 2026 constant-currency revenue guidance of 4.0% to 6.5%, so today’s decline does not appear tied to a fresh earnings miss.

The company also launched a $500 million accelerated share repurchase on May 21, suggesting management has been returning capital even as the stock has remained under pressure.

No obvious new negative filing or company announcement surfaced today, so part of the drop could be because investors are still digesting the index removal and waiting to see whether large-deal momentum converts into stronger second-half revenue.

Sources:

Nasdaq, Cognizant, SEC

Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

$CTSH Insider Trading Activity

$CTSH insiders have traded $CTSH stock on the open market 12 times in the past 6 months. Of those trades, 0 have been purchases and 12 have been sales.

Here’s a breakdown of recent trading of $CTSH stock by insiders over the last 6 months:

MICHAEL PATSALOS-FOX has made 0 purchases and 5 sales selling 15,000 shares for an estimated $1,266,369.
SURYA GUMMADI (President - Americas) has made 0 purchases and 2 sales selling 8,728 shares for an estimated $713,485.
RAVI KUMAR SINGISETTI (Chief Executive Officer) sold 2,950 shares for an estimated $250,934
ALINA KERDMAN (SVP, Controller & CAO) has made 0 purchases and 4 sales selling 625 shares for an estimated $35,486.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.

$CTSH Hedge Fund Activity

We have seen 459 institutional investors add shares of $CTSH stock to their portfolio, and 616 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

GQG PARTNERS LLC added 8,116,278 shares (+inf%) to their portfolio in Q4 2025, for an estimated $673,651,074
MORGAN STANLEY added 5,806,173 shares (+77.8%) to their portfolio in Q1 2026, for an estimated $356,208,713
NOMURA HOLDINGS INC added 4,488,800 shares (+331.8%) to their portfolio in Q1 2026, for an estimated $275,387,880
CITADEL ADVISORS LLC removed 3,697,601 shares (-51.8%) from their portfolio in Q1 2026, for an estimated $226,847,821
NATIONAL BANK OF CANADA /FI/ removed 3,336,295 shares (-57.8%) from their portfolio in Q1 2026, for an estimated $204,681,698
CAPITAL RESEARCH GLOBAL INVESTORS added 3,154,556 shares (+49.6%) to their portfolio in Q1 2026, for an estimated $193,532,010
FMR LLC removed 2,866,441 shares (-80.0%) from their portfolio in Q1 2026, for an estimated $175,856,155

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

$CTSH Congressional Stock Trading

Members of Congress have traded $CTSH stock 3 times in the past 6 months. Of those trades, 1 have been purchases and 2 have been sales.

Here’s a breakdown of recent trading of $CTSH stock by members of Congress over the last 6 months:

REPRESENTATIVE GILBERT RAY CISNEROS, JR. has traded it 2 times. They made 1 purchase worth up to $15,000 on 03/13 and 1 sale worth up to $15,000 on 04/14.
REPRESENTATIVE KEVIN HERN sold up to $50,000 on 03/17.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard. You can access data on congressional stock trades through the Quiver Quantitative API Congress trades endpoint.

$CTSH Analyst Ratings

Wall Street analysts have issued reports on $CTSH in the last several months. We have seen 3 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

Susquehanna issued a "Positive" rating on 05/01/2026
Guggenheim issued a "Buy" rating on 04/30/2026
Wells Fargo issued a "Overweight" rating on 04/30/2026

To track analyst ratings and price targets for $CTSH, check out Quiver Quantitative's $CTSH forecast page.

$CTSH Price Targets

Multiple analysts have issued price targets for $CTSH recently. We have seen 15 analysts offer price targets for $CTSH in the last 6 months, with a median target of $71.0.

Here are some recent targets:

Bryan Keane from Citigroup set a target price of $55.0 on 06/09/2026
Steven Wahrhaftig from Wedbush set a target price of $70.0 on 06/08/2026
Arvind Ramnani from Truist Securities set a target price of $66.0 on 06/01/2026
Dan Dolev from Mizuho set a target price of $68.0 on 05/06/2026
James Friedman from Susquehanna set a target price of $88.0 on 05/01/2026
Jonathan Lee from Guggenheim set a target price of $80.0 on 04/30/2026
Jason Kupferberg from Wells Fargo set a target price of $83.0 on 04/30/2026

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.